204 related articles for article (PubMed ID: 12668816)
1. Renal impairment in patients with multiple myeloma.
Chow CC; Mo KL; Chan CK; Lo HK; Wong KS; Chan JC
Hong Kong Med J; 2003 Apr; 9(2):78-82. PubMed ID: 12668816
[TBL] [Abstract][Full Text] [Related]
2. Haemodialysis using high cut-off dialysers for treating acute renal failure in multiple myeloma.
Martín-Reyes G; Toledo-Rojas R; Torres-de Rueda Á; Sola-Moyano E; Blanca-Martos L; Fuentes-Sánchez L; Martínez-Esteban MD; Díez-de los Ríos MJ; Bailén-García A; González-Molina M; García-González I
Nefrologia; 2012; 32(1):35-43. PubMed ID: 22294003
[TBL] [Abstract][Full Text] [Related]
3. Patients with multiple myeloma have excellent long-term outcomes after recovery from dialysis-dependent acute kidney injury.
Yadav P; Hutchison CA; Basnayake K; Stringer S; Jesky M; Fifer L; Snell K; Pinney J; Drayson MT; Cook M; Cockwell P
Eur J Haematol; 2016 Jun; 96(6):610-7. PubMed ID: 26248588
[TBL] [Abstract][Full Text] [Related]
4. Myeloma renal disease: presentation and outcome.
Chan DT; Craig K; Donovan K; Phillips A
Nephron Clin Pract; 2006; 104(3):c126-31. PubMed ID: 16837814
[TBL] [Abstract][Full Text] [Related]
5. [Survival of myeloma patients treated with dialysis].
Martín Reyes G; Valera A; Frutos MA; Ramos B; Ordóñez V; López de Novales E
Nefrologia; 2003; 23(2):131-6. PubMed ID: 12778877
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors affecting the survival of patients with multiple myeloma. A retrospective analysis of 86 patients.
Rapoport BL; Falkson HC; Falkson G
S Afr Med J; 1991 Jan; 79(2):65-7. PubMed ID: 1989088
[TBL] [Abstract][Full Text] [Related]
7. The Chronic Kidney Disease Epidemiology Collaboration cystatin C (CKD-EPI-CysC) equation has an independent prognostic value for overall survival in newly diagnosed patients with symptomatic multiple myeloma; is it time to change from MDRD to CKD-EPI-CysC equations?
Terpos E; Christoulas D; Kastritis E; Katodritou E; Pouli A; Michalis E; Papassotiriou I; Dimopoulos MA;
Eur J Haematol; 2013 Oct; 91(4):347-55. PubMed ID: 23829647
[TBL] [Abstract][Full Text] [Related]
8. Multiple myeloma can be accurately diagnosed in acute kidney injury patients using a rapid serum free light chain test.
Heaney JLJ; Campbell JP; Yadav P; Griffin AE; Shemar M; Pinney JH; Drayson MT
BMC Nephrol; 2017 Jul; 18(1):247. PubMed ID: 28728609
[TBL] [Abstract][Full Text] [Related]
9. Hemodialysis: an appropriate therapy in myeloma-induced renal failure.
Sharland A; Snowdon L; Joshua DE; Gibson J; Tiller DJ
Am J Kidney Dis; 1997 Dec; 30(6):786-92. PubMed ID: 9398122
[TBL] [Abstract][Full Text] [Related]
10. Bortezomib-based therapy combined with high cut-off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment.
Zannetti BA; Zamagni E; Santostefano M; De Sanctis LB; Tacchetti P; Mancini E; Pantani L; Brioli A; Rizzo R; Mancuso K; Rocchi S; Pezzi A; Borsi E; Terragna C; Marzocchi G; Santoro A; Cavo M
Am J Hematol; 2015 Jul; 90(7):647-52. PubMed ID: 25858483
[TBL] [Abstract][Full Text] [Related]
11. Severe acute kidney injury and multiple myeloma: evaluation of kidney and patient prognostic factors.
Rodrigues L; Neves M; Sá H; Gomes H; Pratas J; Campos M
Eur J Intern Med; 2014 Sep; 25(7):652-6. PubMed ID: 25034390
[TBL] [Abstract][Full Text] [Related]
12. Plasma exchange in rapidly progressive renal failure due to multiple myeloma. A retrospective case series.
Moist L; Nesrallah G; Kortas C; Espirtu E; Ostbye T; Clark WF
Am J Nephrol; 1999; 19(1):45-50. PubMed ID: 10085449
[TBL] [Abstract][Full Text] [Related]
13. Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count.
Perosa F; Minoia C; Favoino E; Prete M; Dammacco F
Blood Cells Mol Dis; 2009; 42(1):71-6. PubMed ID: 18996035
[TBL] [Abstract][Full Text] [Related]
14. Bortezomib-based triplets are associated with a high probability of dialysis independence and rapid renal recovery in newly diagnosed myeloma patients with severe renal failure or those requiring dialysis.
Dimopoulos MA; Roussou M; Gavriatopoulou M; Psimenou E; Eleutherakis-Papaiakovou E; Migkou M; Matsouka C; Mparmparousi D; Gika D; Kafantari E; Ziogas D; Fotiou D; Panagiotidis I; Terpos E; Kastritis E
Am J Hematol; 2016 May; 91(5):499-502. PubMed ID: 26890495
[TBL] [Abstract][Full Text] [Related]
15. Anaemia and type 2 diabetes: implications from a retrospectively studied primary care case series.
Chen CX; Li YC; Chan SL; Chan KH
Hong Kong Med J; 2013 Jun; 19(3):214-21. PubMed ID: 23568938
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of kidney biopsy in myeloma cast nephropathy: a retrospective study of 70 patients.
Ecotière L; Thierry A; Debiais-Delpech C; Chevret S; Javaugue V; Desport E; Belmouaz S; Quellard N; Kaaki S; Goujon JM; Fermand JP; Touchard G; Bridoux F
Nephrol Dial Transplant; 2016 Jan; 31(1):64-72. PubMed ID: 26289418
[TBL] [Abstract][Full Text] [Related]
17. Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors.
Pozzi C; D'Amico M; Fogazzi GB; Curioni S; Ferrario F; Pasquali S; Quattrocchio G; Rollino C; Segagni S; Locatelli F
Am J Kidney Dis; 2003 Dec; 42(6):1154-63. PubMed ID: 14655186
[TBL] [Abstract][Full Text] [Related]
18. Renal impairment in multiple myeloma: A single center experience.
Gorsane I; Barbouch S; Mayara M; Abdelghani KB; Goucha R; Hamida FB; Hedri H; Abdallah TB
Saudi J Kidney Dis Transpl; 2016 May; 27(3):480-5. PubMed ID: 27215238
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis.
Hutchison CA; Heyne N; Airia P; Schindler R; Zickler D; Cook M; Cockwell P; Grima D
Nephrol Dial Transplant; 2012 Oct; 27(10):3823-8. PubMed ID: 22273664
[TBL] [Abstract][Full Text] [Related]
20. IgD multiple myeloma: Clinical, biological features and prognostic value of the serum free light chain assay.
Djidjik R; Lounici Y; Chergeulaïne K; Berkouk Y; Mouhoub S; Chaib S; Belhani M; Ghaffor M
Pathol Biol (Paris); 2015 Sep; 63(4-5):210-4. PubMed ID: 26294067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
